Skip to main content

Table 1 Associations between TFF3 expression in MC and the clinicopathological characteristics of the tumour cohort

From: Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma

Parameter

n

TFF3 positive expression,n(%)

P value

Age (years)

≤35

16

9 (56.3)

0.939

>35- ≤ 55

92

56 (60.9)

>55

51

31 (60.8)

Tumour size (cm)

≤2

13

2 (15.4)

0.002

>2- ≤ 5

115

72 (62.6)

>5

31

22 (71.0)

Lymph node metastasis

0

55

25 (45.5)

0.004

≤3

55

33 (60.0)

>3

49

38 (77.6)

Grade

I

13

7 (53.8)

0.269

II

102

58 (56.9)

III

44

31 (70.5)

Stage

I-II

85

45 (52.9)

0.040

III-IV

74

51 (68.9)

ER^

-

94

54 (57.4)

0.364

+

65

42 (64.6)

PR^^

-

90

54 (60.0)

0.912

+

69

42 (60.9)

ERBB2

low

107

69 (64.5)

0.129

high

52

27 (51.9)

  1. ^ER + required at least 10% staining nuclei; ^^PR + required at least 10% staining nuclei. MC: mammary carcinoma; ER: estrogen receptor; PR: progesterone receptor; ERBB2: v-erb-b2 erythroblastic leukemia viral oncogene homologue 2.